We are looking for children 2 to 17 years of age to join a medical research study to help us discover more about treating gastrointestinal disease. If you are looking for a potential new treatment option for gastrointestinal disease or Crohn’s and UC (including associated symptoms such as cramps, abdominal cramps, rectal pain, malnutrition and/or anemia), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local CD study is testing a potential new medication to see if it may reduce painful joints, inflammation of the bowel or intestine, bloody stool, frequent fevers, and/or canker sores associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the CD study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for young people 2–17 years of age to join a study to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or moderate to severe ulcerative colitis (including associated symptoms such as abdominal pain or cramping, mouth sores, abdominal pain, frequent fevers and/or anemia), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local medical research study is testing a potential new medication to see if it may reduce diarrhea with pus, growth failure, bloody stool, weight loss, and/or anemia associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for children to join a research study to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or UC (including associated symptoms such as painful joints, stomach pain, constant need to poop, frequent fevers and/or liver disease), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing Crohn’s flare-ups? Local CD trial is testing a potential new medication to see if it may reduce abdominal pain, blood in the stool, rectal pain, malnutrition, and/or anemia associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the CD trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for young people 2 to 17 years of age to join a Crohn’s disease (CD) clinical research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or UC (including associated symptoms such as urgency to defecate, growth failure, rectal pain, chronic fatigue and/or canker sores), consider one of our ICD and UC clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the ICD and UC clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing moderately to severely active IBD flare-ups? Local CD research study is testing a potential new medication to see if it may reduce diarrhea, unexplained weight loss, cramps, weight loss, and/or anemia associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the CD research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for children and teenagers 2–17 years of age to join a medical research study to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or gastrointestinal disease (including associated symptoms such as joint pain, failure to thrive, abdominal pain, malnutrition and/or joint pain), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing moderately to severely active IBD flare-ups? Local CD trial is testing a potential new medication to see if it may reduce stomach pain, fistula, constant need to poop, chronic fatigue, and/or liver disease associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the CD trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.